Assamese writer Sarmistha Pritam Baruah seeks government aid for medical treatment

She has spinal muscular atrophy, treatment of which runs into crores of rupees

October 09, 2021 02:21 pm | Updated 02:21 pm IST - GUWAHATI:

An Assamese writer has sought support from the State government for treatment of spinal muscular atrophy (SMA), a rare degenerative neuromuscular disease that requires medicines – now available in India – worth at least ₹4 crore at ₹72 lakh per annum for up to nine years.

Sarmistha Pritam Baruah, based at Phulaguri in central Assam’s Nagaon district, has also advocated a health scheme for people with SMA.

Following her appeal, Assam Health Minister Keshab Mahanta visited the wheelchair-bound Ms. Baruah at her residence on August 22. He had assured her of action after discussion with Chief Minister Himanta Biswa Sarma.

“I am still awaiting communication from the government,” she told The Hindu on October 9.

A life member of Ellora Vigyan Mancha, an NGO that spreads scientific temper and promotes organ donation, Ms. Baruah has won several literary awards.

She was diagnosed with SMA at the age of 5. “My parents arranged physiotherapy sessions, as per the doctor’s advice for the first few years but had discontinued them after some time. They did not know much about SMA at that time and my condition deteriorated due to wrong treatment plans,” she said.

Ms. Baruah has been facing hardship after Alzheimer’s disease took a toll on her father and her mother started suffering from hypertension and backache.

“Even after bearing the pain and difficulties, I have been trying to establish myself as a valued human resource,” she added.

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.